| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.11 | 0.009 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.12 | 0.009 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.098 | 0.03 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.093 | 0.04 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.088 | 0.06 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.066 | 0.1 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.065 | 0.1 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.064 | 0.2 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.077 | 0.2 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.055 | 0.2 |